Product image of Carvykti (Ciltacabtagene Autoleucel) supplied by GNH India

Carvykti

Active Ingredient:
Ciltacabtagene Autoleucel
Origin:
EU

Carvykti (Ciltacabtagene Autoleucel)

Carvykti (ciltacabtagene autoleucel) is a cutting-edge parenteral medication used in advanced therapeutic settings. This innovative treatment is designed to target specific cells in the body, offering a novel approach to certain medical conditions.

Manufacturer / TM Owner

Janssen-Cilag International Nv

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Carvykti is primarily used in specialized medical treatments where targeted cell therapy is required. It is often considered for conditions that involve abnormal cell growth or dysfunction. Patients and healthcare providers may explore Carvykti uses when other treatments have not been effective. The specific applications of Carvykti are determined by medical professionals based on individual patient needs.

Side Effects

  • Carvykti works by interacting with the body's immune system to target and affect specific cells. This can lead to various effects, including changes in immune response and cell activity. Patients may experience a range of reactions as their body adjusts to the treatment. Common effects can vary widely and should be discussed with a healthcare provider.

Precautions & Warnings

  • Carvykti should be handled with care and administered under strict medical supervision. It is crucial to follow all safety guidelines provided by healthcare professionals. Patients should be monitored closely for any adverse reactions. Proper storage and handling procedures must be adhered to ensure the safety and efficacy of the treatment.

Avoid Interactions

  • Carvykti may interact with other medications or treatments, particularly those that affect the immune system. It is important to inform healthcare providers about all current medications and treatments before starting Carvykti. Alcohol and certain supplements may also interact with Carvykti, so patients should discuss their lifestyle and supplement use with their healthcare provider.

Frequently Asked Questions

Carvykti is used in specialized medical treatments where targeted cell therapy is required, often for conditions involving abnormal cell growth or dysfunction.

Carvykti is administered parenterally, meaning it is introduced into the body through methods other than the digestive tract, such as injection or infusion.

Common effects of Carvykti can include changes in immune response and cell activity, with reactions varying widely among patients.

Yes, Carvykti should be administered under strict medical supervision, and patients should be monitored closely for any adverse reactions.

Carvykti may interact with other medications, especially those affecting the immune system, so it is important to discuss all current treatments with a healthcare provider.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated:

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Ciltacabtagene Autoleucel

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT